The importance of individual differences in response to opioid therapy

Therapy

Volumn 6, Issue 5, 2009, Pages 633-635

  Dahan, Albert ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 2D6; MELANOCORTIN 1 RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; MULTIDRUG RESISTANCE PROTEIN 1; OPIATE;

CANCER PAIN; COMORBIDITY; CONSTIPATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG METABOLISM; DRUG SENSITIVITY; EDITORIAL; GENETIC DIFFERENCE; GENOTYPE; HUMAN; NAUSEA; NONHUMAN; PATIENT CONTROLLED ANALGESIA; PHARMACOGENETICS; POSTOPERATIVE PAIN; RESPIRATION DEPRESSION; SOMNOLENCE; TREATMENT RESPONSE; VOMITING;

EID: 70449481820     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.2217/thy.09.44     Document Type: Editorial

References (17)

1. Galley HF, Mahdy A, Lowes DA: Pharmacogenetics and anesthesiologists. Pharmacogenomics 6, 849-856 (2005).
2. Wiesenfeld-Hallin Z: Sex differences in pain perception. Gend. Med. 2, 137-145 (2005)
3. Chin ML, Rosenquist R: Sex, gender, and pain: 'men are from Mars, women are from Venus ...' Anesth. Analg. 107, 4-5 (2008).
4. Miaskowski C, Levine JD: Does opioid analgesia show a gender preference for females? Pain Forum 8, 34-44 (1999).
5. Chia YY, Chow LH, Hung CC et al.: Gender and pain upon movement are associated with the requirements for postoperative patient-controlled i.v. analgesia: a prospective survey of 2298 Chinese patients. Can. J. Anaesth. 49, 249-255 (2002).
6. Dahan A, Sarton E, Teppema L, Olievier CN: Sex-related differences in influence of morphine on ventilatory control in humans. Anesthesiology 88, 903-913 (1998). (Pubitemid 28193316)
7. Sarton E, Dahan A, Teppema L: Sex differences in morphine-induced ventilatory depression resides within the peripheral chemoreflex loop. Anesthesiology 90, 1329-1338 (1999). (Pubitemid 29205637)
8. Sarton E, Olofsen E, Romberg R et al.: Sex differences in morphine analgesia: an experimental study in healthy volunteers. Anesthesiology 93, 1245-1254 (2000). (Pubitemid 30822839)
9. Searle R, Hopkins PM: Pharmacogenomic variability and anaesthesia. Br. J. Anaesth. 103(1), 14-25 (2009).
10. Lötsch J, von Hentig N, Freynhagen R et al.: Cross-sectional ana lysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers. Pharmacogenet. Genomics 19, 429-436 (2009).
11. Rakvåg TT, Ross JR, Sato H et al.: Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain. Mol. Pain 4, 64-73 (2008).
12. Landau R, Cahana A, Smiley RM et al.: Genetic variability of μ-opioid receptor in an obstetric population. Anesthesiology 100, 1030-1033 (2004). (Pubitemid 38392598)
13. Oertel BG, Schmidt R, Schneider A et al.: The μ-opioid receptor gene polymorphism 118A >G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers. Pharmacogenet. Genomics 16, 625-636 (2006). (Pubitemid 44223074)
14. Lötsch J, Skarke C, Wieting J et al.: Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action. Clin. Pharmacol. Ther. 79, 72-89 (2006).
15. Romberg R, Olofsen E, Bijl H et al.: Polymorphism of μ-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response. Anesthesiology 102, 522-530 (2005). (Pubitemid 40315140)
16. Park HJ, Shinn HK, Ryu SH et al.: Genetic polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans. Clin. Pharmacol. Ther. 81, 1-8 (2007).
17. Koren G, Cairns J, Chitayat D et al.: Phramacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet 368, 704 (2006). (Pubitemid 44223697)